Sen. Wyden Releases Interim Report in Big Pharma Tax Investigation
July 08, 2022
July 08, 2022
WASHINGTON, July 8 (TNSres) -- Sen. Ron Wyden, D-Oregon, chairman of the Senate Finance Committee, issued the following news release on July 7, 2022:
Senate Finance Committee Chair Ron Wyden, D-Ore., today released an interim report in his investigation into Big Pharma's tax practices. Wyden's report shows how loopholes in the tax code have allowed AbbVie, a large multinational corporation headquartered in the United States, to further abuse tax havens and avoid paying U.S. taxes on . . .
Senate Finance Committee Chair Ron Wyden, D-Ore., today released an interim report in his investigation into Big Pharma's tax practices. Wyden's report shows how loopholes in the tax code have allowed AbbVie, a large multinational corporation headquartered in the United States, to further abuse tax havens and avoid paying U.S. taxes on . . .